Sort
50,496 grants matching “lung cancer”
The Effect of Diet and Nutrients on the Progression and Treatment of Prostate Can
$614,635George Thomas · University Of Cincinnati · U01 · FY2011 · CA
Optimization of MeV FLASH radiotherapy for normal tissue preservation
$614,605Brian William Pogue · Dartmouth College · U01 · FY2025 · CA
Biomarkers to Assess Selenium Chemoprevention for NSCLC
$614,592Lovelace Biomedical &Environmental Res · R01 · FY2003 · CA
FAMILY HOME CARE FOR CANCER--A COMMUNITY BASED MODEL
$614,588Michigan State University · R01 · FY2000 · CA
Epigenetic Drivers of Cancer (PQ 10)
$614,511Peter W Laird · University Of Southern California · R01 · FY2012 · CA
Adenocarinoma of the Lung in Women
$614,505Wayne State University · R01 · FY2004 · CA
Evaluating the implementation and impact of navigator-delivered ePRO home symptom monitoring and management
$614,457Gabrielle Rocque · University Of Alabama At Birmingham · R01 · FY2025 · NR
Genotype and Imaging Phenotype Biomarkers in Lung Cancer
$614,450Hugo Aerts · Dana-Farber Cancer Inst · U01 · FY2019 · CA
Therapeutic Targeting Mitochondrial C1 Metabolism
$614,438Larry H. Matherly · Wayne State University · R01 · FY2025 · CA
Characterizing Genetic Susceptibility to Breast and Prostate Cancer; the BPC3
$614,408Elio Riboli · Imperial College Of Science, Technology And Medicine · U01 · FY2011 · CA
Basic applications for total-body PET in oncology
$614,406Lorenzo Nardo · University Of California At Davis · R01 · FY2021 · CA
Evaluation of Patients with Low-Risk and Intermediate-Risk Prostate Cancer Scheduled for High-Dose Rate Brachytherapy Using 68Ga-RM2 PET, 68Ga-PSMA-11 PET and Multi Parametric MRI
$614,344Andrei Iagaru · Stanford University · R01 · FY2019 · CA
Protein and proteolytic activity biomarkers of early stage pancreatic cancer
$614,311Paul Tempst · Sloan-Kettering Inst Can Research · R01 · FY2019 · CA
A Registry-Based Study of Patterns of Use of Targeted Therapies for Metastatic Cancers in Diverse Populations
$614,203Christine Veenstra · University Of Michigan At Ann Arbor · R37 · FY2024 · CA
ClinSeq(c) - Molecular and Genetic Aspects
$614,171Leslie Biesecker · National Human Genome Research Institute · ZIA · FY2013 · HG
Estimating Overdiagnosis in Cancer Screening Studies
$614,029Ruth D Etzioni · Fred Hutchinson Cancer Research Center · R01 · FY2017 · CA
Personalized Motion Management for Truly 4D Lung Radiotherapy
$613,955Amit Sawant · University Of Maryland Baltimore · R01 · FY2022 · CA
Programmable encapsulation systems to improve delivery of therapeutic bacteria
$613,945Tal Danino · Columbia Univ New York Morningside · R01 · FY2023 · EB
The Early Detection Research Network: Biomarker Referen*
$613,916University Of California Los Angeles · U24 · FY2005 · CA
MID ATLANTIC PROSTATE CANCER BANK
$613,904George Washington University · U01 · FY2001 · CA
Multiplexed Nanosensing for DNA and Proteins
$613,878Richard James Cote · University Of Southern California · R01 · FY2007 · EB
Autoantibodies to tumor-derived neoepitopes as biomarkers and immunoPET agents for the early detection of small cell lung cancer
$613,760Paul D Lampe · Fred Hutchinson Cancer Center · R01 · FY2024 · CA
Providing Tobacco Treatment to Patients Undergoing Lung Cancer Screening at MedStar Health: A Randomized Trial
$613,709Kathryn L Taylor · Georgetown University · R01 · FY2024 · CA
Multi-level interventions for addressing tobacco cessation and SDOH in Community Health Centers (CHCs)
$613,701Chelsey Schlechter · University Of Utah · U54 · FY2023 · CA
Mechanistic factors limiting utility of adenovirus vectors for treatment of neopla
$613,600Dmitry Shayakhmetov · Emory University · R01 · FY2023 · CA